Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Resmed Inc (RMD)

Resmed Inc (RMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 35,697,168
  • Shares Outstanding, K 145,941
  • Annual Sales, $ 5,146 M
  • Annual Income, $ 1,401 M
  • EBIT $ 1,792 M
  • EBITDA $ 2,028 M
  • 60-Month Beta 0.87
  • Price/Sales 7.00
  • Price/Cash Flow 22.02
  • Price/Book 5.88

Options Overview Details

View History
  • Implied Volatility 27.92% (+0.90%)
  • Historical Volatility 22.16%
  • IV Percentile 45%
  • IV Rank 20.82%
  • IV High 56.66% on 04/08/25
  • IV Low 20.36% on 08/13/25
  • Expected Move (DTE 22) 12.92 (5.29%)
  • Put/Call Vol Ratio 1.13
  • Today's Volume 17
  • Volume Avg (30-Day) 161
  • Put/Call OI Ratio 3.13
  • Today's Open Interest 18,432
  • Open Int (30-Day) 24,649
  • Expected Range 231.52 to 257.36

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 2.68
  • Number of Estimates 6
  • High Estimate 2.74
  • Low Estimate 2.63
  • Prior Year 2.43
  • Growth Rate Est. (year over year) +10.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
237.63 +2.87%
on 12/01/25
259.99 -5.98%
on 12/10/25
-6.08 (-2.43%)
since 11/24/25
3-Month
237.63 +2.87%
on 12/01/25
284.87 -14.19%
on 10/08/25
-29.75 (-10.85%)
since 09/24/25
52-Week
199.92 +22.27%
on 04/07/25
293.81 -16.80%
on 08/22/25
+11.86 (+5.10%)
since 12/24/24

Most Recent Stories

More News
1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

1 Cash-Producing Stock Worth Your Attention and 2 We Brush Off

WDFC : 204.89 (+0.63%)
RMD : 244.44 (-0.07%)
CR : 188.27 (-0.38%)
Resmed Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference

SAN DIEGO, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present...

RMD.AX : 36.220 (-2.06%)
RMD : 244.44 (-0.07%)
2 Healthcare Stocks on Our Watchlist and 1 We Brush Off

2 Healthcare Stocks on Our Watchlist and 1 We Brush Off

INSP : 95.65 (+0.71%)
RMD : 244.44 (-0.07%)
SGRY : 15.63 (+0.64%)
Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has received...

RMD.AX : 36.220 (-2.06%)
RMD : 244.44 (-0.07%)
Is ResMed Stock Underperforming the S&P 500?

Though ResMed has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects.

$SPX : 6,932.05 (+0.32%)
RMD : 244.44 (-0.07%)
ISRG : 577.15 (-0.03%)
1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds

1 Safe-and-Steady Stock with Competitive Advantages and 2 Facing Headwinds

RMD : 244.44 (-0.07%)
NEOG : 7.14 (-0.14%)
CBSH : 53.03 (-0.34%)
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know

CORT : 83.59 (+1.95%)
ELAN : 22.38 (+0.72%)
LMAT : 84.34 (+0.44%)
PEN : 315.86 (-0.03%)
RMD : 244.44 (-0.07%)
Are Wall Street Analysts Predicting ResMed Stock Will Climb or Sink?

ResMed has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

$SPX : 6,932.05 (+0.32%)
RMD : 244.44 (-0.07%)
IHI : 62.73 (+0.14%)
1 Large-Cap Stock to Target This Week and 2 We Brush Off

1 Large-Cap Stock to Target This Week and 2 We Brush Off

STT : 132.22 (+1.16%)
DHI : 146.63 (+1.50%)
RMD : 244.44 (-0.07%)
1 S&P 500 Stock to Research Further and 2 We Turn Down

1 S&P 500 Stock to Research Further and 2 We Turn Down

BF.B : 26.89 (+0.94%)
RMD : 244.44 (-0.07%)
URI : 824.77 (+0.85%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory...

See More

Key Turning Points

3rd Resistance Point 246.61
2nd Resistance Point 246.03
1st Resistance Point 245.24
Last Price 244.44
1st Support Level 243.87
2nd Support Level 243.29
3rd Support Level 242.50

See More

52-Week High 293.81
Fibonacci 61.8% 257.94
Fibonacci 50% 246.86
Last Price 244.44
Fibonacci 38.2% 235.79
52-Week Low 199.92

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar